![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Noramco Buprenorphine Hydrochloride](https://www.pharmacompass.com/image/flap/noramco-buprenorphine-hydrochloride-desktop-headergif-2507.gif)
![Noramco Buprenorphine Hydrochloride](https://www.pharmacompass.com/image/flap/noramco-buprenorphine-hydrochloride-mob-headergif-29638.gif)
X
01 Noramco (2)
02 Mallinckrodt Plc (1)
03 USP (1)
01 209963-02-0 (1)
02 53152-21-9 (2)
03 Blank (1)
01 EP Impurity B; Dealkylbuprenorphine; USP Impurity (1)
02 Material Origin- Chemical Synthesis; USMCA- No; KORUS- No; Base Control Drug- BUPREN ORPHINE; Base Control Drug %- 92.8 (1)
03 Blank (2)
01 Ireland (1)
02 U.S.A (3)